Lifespan.io, renowned for its unwavering advocacy for longevity and responsible journalism, is joining hands with SENS Research Foundation, a trailblazer in longevity-focused research and a pioneer of the damage-repair approach to combating aging. Together, these organizations bring a formidable quarter-century of combined expertise to the table. Their collaborative efforts have propelled the field forward and been instrumental in garnering recognition for longevity research as a vital and transformative industry.

This merger signifies a new chapter in the quest for extended human healthspan—a journey fueled by innovation, passion, and a shared commitment to bringing the diseases of aging under medical control. With their complementary strengths and shared vision, the newly formed nonprofit promises to lead the charge towards a future where aging is no longer a barrier to a life well lived.

We are incredibly excited to announce this merger. Both Lifespan.io and SENS Research Foundation are respected nonprofits that were founded well before longevity biotechnology was a mainstream topic, and both were created to catalyze scientific breakthroughs. Since that time, technological innovation, dedicated advocacy, and political support have driven the significant evolution of the industry’s landscape. We will move forward into an exciting future as a united front, leveraging our strengths and resources to accelerate progress towards extending healthy human lifespan for everyone.

A New Approach
This merger represents a deliberate alignment of research and advocacy efforts, uniting them toward the immediate goal of expediting advancements in extending healthy human lifespan instead of waiting for the distant future. With an aim of bolstering the industry at large, they will offer a platform for information creation and dissemination to foster global impact. By pooling together resources, expertise, and networks, the newly formed entity is positioned to significantly influence the progress of rejuvenation biotechnologies while enhancing public awareness and involvement.

This marks an exhilarating new chapter for SRF and the longevity industry as a whole. Throughout the years, we’ve collaborated closely with Lifespan.io to promote our research, benefiting from their unparalleled expertise in distributing information to drive awareness and engagement in longevity research. By combining our scientific prowess with their outreach capabilities, we will drive the advent of new technologies and therapies for the extension of healthspan. These types of connections are what will propel our industry forward.

Looking Ahead
Upon completion of the regulatory process, the merger is slated to be finalized by the end of 2024. Lisa Fabiny-Kiser as Chief Executive Officer and Stephanie Dainow as Chief Business Officer are poised to be Co-Founders of this new entity, joined by an equally representative Board of Directors. By leveraging their combined strengths and a redoubled focus on impactful and translatable research, the merged organization will serve a key sense-making and unifying role for the longevity industry, accelerating the development, translation, and equitable distribution of therapies to increase healthy human lifespan.

Source: https://www.lifespan.io/news/sens-lifespan-merge/